Medicare Enrolled

Dr. Eunice Wang, MD

Hematology · Buffalo, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
ELM AND CARLTON STREETS, Buffalo, NY 14263
7168452300
In practice since 2005 (20 years)
NPI: 1386625598 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wang

Dr. Eunice Wang is a hematology specialist in Buffalo, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 284 Medicare services across 124 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wang received a total of $358,028 from 36 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 284 Medicare services $358,028 industry payments

Medicare Practice Summary

Medicare Utilization ↗
284
Medicare services
Bottom 42% in NY for hematology
124
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
77 $24 $53
Prolonged inpatient or observation care, each additional 15 minutes
This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider.
61 $23 $124
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
58 $108 $407
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
36 $61 $310
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
29 $91 $384
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $71 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$358,028
Total received (2018-2024)
Avg $51,147/year across 7 years
Top 5% in NY for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$290,578 (81.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$62,660 (17.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,791 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$33,454
2023
$25,713
2022
$43,568
2021
$53,527
2020
$37,690
2019
$73,570
2018
$90,507

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$9,952
Gilead Sciences, Inc.
$8,647
Takeda Pharmaceuticals U.S.A., Inc.
$3,299
Stemline Therapeutics Inc.
$3,151
Kite Pharma, Inc.
$2,620
Novartis Pharmaceuticals Corporation
$2,513
Blueprint Medicines Corporation
$1,866
JAZZ PHARMACEUTICALS INC.
$368
Rigel Pharmaceuticals, Inc.
$353
Astellas Pharma US Inc
$296
ABBVIE INC.
$178
AstraZeneca Pharmaceuticals LP
$100
Astellas Pharma Inc
$59
PharmaEssentia USA Corporation
$52
Top 3 companies account for 65.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$62,347
Kite Pharma, Inc.
$39,450
Daiichi Sankyo Inc.
$32,396
Gilead Sciences, Inc.
$29,188
Novartis Pharmaceuticals Corporation
$25,622
Stemline Therapeutics Inc.
$22,620
Astellas Pharma US Inc
$21,057
Jazz Pharmaceuticals Inc.
$18,538
AbbVie Inc.
$10,613
Amgen Inc.
$9,850
Celgene Corporation
$9,728
GlaxoSmithKline, LLC.
$8,775
PFIZER INTERNATIONAL LLC
$8,735
Agios Pharmaceuticals, Inc.
$7,948
JAZZ PHARMACEUTICALS INC.
$7,394
Takeda Pharmaceuticals U.S.A., Inc.
$6,038
Janssen Global Services, LLC
$5,525
WHITEHALL INTERNATIONAL INC
$4,312
E.R. Squibb & Sons, L.L.C.
$4,176
Rigel Pharmaceuticals, Inc.
$4,013
AbbVie, Inc.
$3,154
Genentech, Inc.
$2,970
ImmunoGen, Inc.
$2,940
ABBVIE INC.
$2,678
Genentech USA, Inc.
$2,197
Blueprint Medicines Corporation
$1,966
CTI BioPharma Corp.
$1,500
PTC Therapeutics, Inc.
$1,317
Foundation Medicine, Inc.
$400
AstraZeneca Pharmaceuticals LP
$186
Servier Pharmaceuticals LLC
$141
Alexion Pharmaceuticals, Inc.
$96
Astellas Pharma Inc
$59
PharmaEssentia USA Corporation
$52
Astellas Pharma Global Development
$29
Sobi, Inc
$15
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · BESPONSA · BESREMI · BOSULIF · Blincyto · DAURISMO · DEFITELIO · DOPTELET · ELREXFIO · ELZONRIS · FOUNDATIONACT · ICLUSIG · INREBIC · MYLOTARG · Non-Covered Product · ONCASPAR · ONUREG · RYDAPT · RYLAZE · Revlimid · Rezlidhia · SCEMBLIX · SOLIRIS · TASIGNA · TIBSOVO · Tavalisse · Tecartus · VENCLEXTA · VYXEOS · Vanflyta · Venclexta · Vidaza · Vonjo · XOSPATA · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for hematology in NY.

Looking for a hematology specialist in Buffalo?
Compare hematologists in the Buffalo area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wang is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 5% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wang experienced with prolonged office e/m service, first 15 minutes?
Based on Medicare claims data, Dr. Wang performed 77 prolonged office e/m service, first 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $358,028 from 36 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other hematologists in Buffalo?
Dr. Wang's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →